List of bibliographic references indexed by studies
Number of relevant bibliographic references: 38.
[0-20] [
0 - 20][
0 - 38][
20-37][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000093 (2021) |
Derek Shyr [États-Unis] ; Yu Shyr [États-Unis] | The design and analysis of non-randomized studies: a case study of off-label use of hydroxychloroquine in the COVID-19 pandemic. |
| 000097 (2021) |
Jack Cook [États-Unis] ; Milton L. Pressler [États-Unis] ; Bharat Damle [États-Unis] ; Demissie Alemayehu [États-Unis] ; Charles A. Knirsch [États-Unis] | The Weight of Evidence From Electrophysiology, Observational, and Cardiovascular End Point Studies Demonstrates the Safety of Azithromycin. |
| 000116 (2021) |
Sathishkumar Chidambaram [Inde] ; Mohamed A. El-Sheikh [Arabie saoudite] ; Ahmed H. Alfarhan [Arabie saoudite] ; Surendrakumar Radhakrishnan [Inde] ; Idhayadhulla Akbar [Inde] | Synthesis of novel coumarin analogues: Investigation of molecular docking interaction of SARS-CoV-2 proteins with natural and synthetic coumarin analogues and their pharmacokinetics studies. |
| 000128 (2021) |
Deepak Mishra [Inde] ; Radha Raman Maurya [Inde] ; Kamlesh Kumar [Inde] ; Nupur S. Munjal [Inde] ; Vijay Bahadur [Inde] ; Sandeep Sharma [Inde] ; Prashant Singh [Inde] ; Indra Bahadur [Afrique du Sud] | Structurally modified compounds of hydroxychloroquine, remdesivir and tetrahydrocannabinol against main protease of SARS-CoV-2, a possible hope for COVID-19: Docking and molecular dynamics simulation studies. |
| 000129 (2021) |
Sinosh Skariyachan [Inde] ; Dharshini Gopal [Inde] ; Aditi G. Muddebihalkar [Inde] ; Akshay Uttarkar [Inde] ; Vidya Niranjan [Inde] | Structural insights on the interaction potential of natural leads against major protein targets of SARS-CoV-2: Molecular modelling, docking and dynamic simulation studies. |
| 000213 (2021) |
Nicolas Dauby [Belgique] ; Joris Hautekiet [Belgique] ; Lucy Catteau [Belgique] ; Marion Montourcy [Belgique] ; Dominique Van Beckhoven [Belgique] ; Emmanuel Bottieau [Belgique] ; Els Goetghebeur [Belgique] | Reply to "The perceived efficacy of hydroxychloroquine in observational studies: the results of the confounding effects of 'goals of care'". |
| 000233 (2021) |
Olfa Noureddine [Tunisie] ; Noureddine Issaoui [Tunisie] ; Mouna Medimagh [Tunisie] ; Omar Al-Dossary [Arabie saoudite] ; Houda Marouani [Tunisie] | Quantum chemical studies on molecular structure, AIM, ELF, RDG and antiviral activities of hybrid hydroxychloroquine in the treatment of COVID-19: Molecular docking and DFT calculations. |
| 000271 (2021) |
Ahmed A. Ishola [Nigeria] ; Kayode E. Adewole [Nigeria] ; Habibu Tijjani [Nigeria] ; Suliat I. Abdulai [Nigeria] ; Nnaemeka T. Asogwa [Nigeria] | Phylogenic analysis of coronavirus genome and molecular studies on potential anti-COVID-19 agents from selected FDA-approved drugs. |
| 000276 (2021) |
Nida Bokharee [Pakistan] ; Yusra Habib Khan ; Aisha Khokhar [Pakistan] ; Tauqeer Hussain Mallhi ; Nasser Hadal Alotaibi ; Maria Rasheed [Pakistan] | Pharmacological interventions for COVID-19: a systematic review of observational studies and clinical trials. |
| 000284 (2021) |
Prof Imad M. Tleyjeh [Arabie saoudite] ; Haytham Tlayjeh [Arabie saoudite] | Perceived efficacy of hydroxychloroquine in observational studies: Results of the confounding effect of "goals of care". |
| 000304 (2021) |
Sandra Elizabeth Barbosa Da Silva ; José Arion Da Silva Moura ; Tiago Rafael De Sousa Nunes ; Ivan Da Rocha Pitta ; Marina Galdino Da Rocha Pitta | New Trends On Biological Activities And Clinical Studies Of Quinolinic Analogues: A Review. |
| 000331 (2021) |
Haruna Isiyaku Umar [Nigeria, Inde] ; Bushra Siraj [Inde, Pakistan] ; Adeola Ajayi [Nigeria] ; Tajudeen O. Jimoh [Thaïlande, Ouganda] ; Prosper Obed Chukwuemeka [Nigeria] | Molecular docking studies of some selected gallic acid derivatives against five non-structural proteins of novel coronavirus. |
| 000555 (2021) |
Milo Gatti [Italie] ; Fabrizio De Ponti [Italie] | Drug Repurposing in the COVID-19 Era: Insights from Case Studies Showing Pharmaceutical Peculiarities. |
| 000707 (2021) |
Christel Renoux [Canada] ; Laurent Azoulay [Canada] ; Samy Suissa [Canada] | Biases in evaluating the safety and effectiveness of drugs for covid-19: designing real-world evidence studies. |
| 000911 (2020) |
Silvano Esposito [Italie] ; Silvana Noviello [Italie] ; Pasquale Pagliano [Italie] | Update on treatment of COVID-19: ongoing studies between promising and disappointing results. |
| 000A34 (2020) |
Kai Kupferschmidt | U.K. megatrial outshines other drug studies. |
| 000B83 (2020) |
Jacques Fantini [France] ; Henri Chahinian [France] ; Nouara Yahi [France] | Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal. |
| 000B84 (2020) |
Jacques Fantini [France] ; Henri Chahinian [France] ; Nouara Yahi [France] | Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal. |
| 000B98 (2020) |
Jacques Fantini [France] ; Coralie Di Scala [France] ; Henri Chahinian [France] ; Nouara Yahi [France] | Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection. |
| 000B99 (2020) |
Sinosh Skariyachan [Inde] ; Dharshini Gopal [Inde] ; Shweta Chakrabarti [Inde] ; Priya Kempanna [Inde] ; Akshay Uttarkar [Inde] ; Aditi G. Muddebihalkar [Inde] ; Vidya Niranjan [Inde] | Structural and molecular basis of the interaction mechanism of selected drugs towards multiple targets of SARS-CoV-2 by molecular docking and dynamic simulation studies- deciphering the scope of repurposed drugs. |
| 000C05 (2020) |
Rashi Srivastava ; Shubham Tripathi ; Sreepoorna Unni ; Arif Hussain ; Shafiul Haque ; Nandita Dasgupta ; Vineeta Singh ; Bhartendu Nath Mishra | Silybin B and Cianidanol Inhibit M pro and Spike Protein of SARS-CoV-2: Evidence from in Silico Molecular Docking Studies. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "studies"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i \
-Sk "studies" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= Title.i
|clé= studies
}}
| This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021 |  |
